The latest update is out from Amesite ( (AMST) ).

On July 17, 2026, Amesite Inc. entered into an at-the-market offering agreement with H.C. Wainwright & Co. LLC, enabling the company to issue and sell common stock from time to time under an existing shelf registration statement. The arrangement allows sales through ordinary broker transactions on The Nasdaq Capital Market, subject to limits on registered and authorized shares and the constraints of Form S-3.

The company is not obligated to sell any shares and the agent is not required to buy on a principal basis, with commissions set at 3% of gross proceeds and Amesite covering specified expenses and indemnification obligations. Any net proceeds from potential share sales are intended for general corporate and working capital purposes, giving management broad discretion over use of funds, which may affect capital structure and liquidity depending on how extensively the program is utilized.